Company intelligence / Profile preview

MUSE Microscopy, Inc.

Irvine, California, United Statesmusemicroscopy.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed SmartPath, a slide-free direct-to-digital tissue imaging system using ultraviolet surface excitation. It produces high-resolution H&E-equivalent images from fresh or formalin-fixed tissue within minutes. The system aims to eliminate traditional glass slides and toxic chemicals from histopathology workflows. As of May 2025, the product remains intended for research use only and pending FDA approval; no clinical trial results are available yet.

Therapeutic areas: Oncology
Modalities: N/A—diagnostic device/platform
Industry: Pathology

Beyond the preview

Go deeper on MUSE Microscopy, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MUSE Microscopy, Inc..

Explore the full profile